Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03245489 |
|---|---|
| Brief Title: | Pembrolizumab in Combination With Anti-platelet Therapy for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
| First Submitted : | June 13, 2017 |
| First Submitted that Met QC Criteria : | August 9, 2017 |
| First Posted : | August 10, 2017 |
| Last Update Submitted that Met QC Criteria : | April 29, 2024 |
| Last Update Posted : | April 30, 2024 |